BGI
Top Five Articles on GenomeWeb Last Week: Mursla Bio Liver Test, GeneDx Stock Drop, More
Last week, GenomeWeb's readers were most interested in Mursla Bio prepping its liver cancer test for commercialization.
The Chinese firm saw increasing domestic competition while geopolitics impacted its multiomics and synthetic biology service business in the Americas.
Complete Genomics Inks Deals With Human Cell Atlas Project, BioTuring for Spatial Bio Products
As the exclusive US distributor of BGI's STOmics Tech, Complete Genomics aims to boost the adoption of its spatial transcriptomics product offerings.
In Brief This Week: MDxHealth, ERS Genomics, Helix, Cerca Biotech, Shuwen Biotech, More
News items for the week of Jan. 13, 2025.
Both short-read and long-read instrument makers are fleshing out their multiomics menus as they hope to gain a share of the fast-evolving market.
Nov 22, 2024
Sep 10, 2024
House Passes Biosecure Act With Bipartisan Support
Aug 26, 2024
Aug 23, 2024
Jun 18, 2024
Apr 17, 2024